NCT01417494View on ClinicalTrials.gov

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

April 30, 2016

Conditions
Colorectal Cancer
Interventions
DRUG

Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen)

DRUG

Chemotherapy ( FOLFIRI regimen, FOLFOX regimen or LV5FU2 regimen) + bevacizumab

Trial Locations (1)

93000

Hôpital Avicenne, Bobigny

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT01417494 - 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter